# | Title | Journal | Year | Citations |
---|
|
1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 4,789 |
2 | Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 | Cell Death and Differentiation | 2018 | 4,451 |
3 | Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer | New England Journal of Medicine | 2004 | 4,181 |
4 | The Somatic Genomic Landscape of Glioblastoma | Cell | 2013 | 4,133 |
5 | Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck | New England Journal of Medicine | 2016 | 4,020 |
6 | One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States | Journal of Clinical Oncology | 2008 | 3,948 |
7 | The future of immune checkpoint therapy | Science | 2015 | 3,896 |
8 | Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy | Cell | 2017 | 3,753 |
9 | Guidelines for the use and interpretation of assays for monitoring autophagy | Autophagy | 2012 | 3,158 |
10 | Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis | Journal of Clinical Oncology | 2005 | 2,678 |
11 | Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Nature Genetics | 1997 | 2,618 |
12 | Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States | JAMA Oncology | 2017 | 2,475 |
13 | Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer | Journal of Clinical Oncology | 2008 | 2,450 |
14 | Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System | Journal of Clinical Oncology | 2001 | 2,410 |
15 | Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy | Journal of Clinical Oncology | 2004 | 2,345 |
16 | Glypican-1 identifies cancer exosomes and detects early pancreatic cancer | Nature | 2015 | 2,345 |
17 | A Landscape of Driver Mutations in Melanoma | Cell | 2012 | 2,306 |
18 | Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers | Journal of the National Cancer Institute | 2005 | 2,217 |
19 | Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial | Lancet Oncology, The | 2009 | 2,177 |
20 | Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma | Journal of Clinical Oncology | 2015 | 2,075 |
21 | Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer | New England Journal of Medicine | 1999 | 2,047 |
22 | Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer | Nature | 2015 | 2,035 |
23 | Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential | Cell | 2015 | 1,950 |
24 | Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer | Journal of Clinical Oncology | 2004 | 1,926 |
25 | Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy | Cancer | 2006 | 1,907 |
26 | Landscape of somatic mutations in 560 breast cancer whole-genome sequences | Nature | 2016 | 1,836 |
27 | Advances and Challenges of Liposome Assisted Drug Delivery | Frontiers in Pharmacology | 2015 | 1,780 |
28 | Chimeric antigen receptor T-cell therapy — assessment and management of toxicities | Nature Reviews Clinical Oncology | 2018 | 1,763 |
29 | Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma | Cell | 2016 | 1,758 |
30 | Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual | Ca-A Cancer Journal for Clinicians | 2017 | 1,748 |
31 | Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide | Nature | 2007 | 1,716 |
32 | PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients | Cancer Cell | 2004 | 1,711 |
33 | The Human Cell Atlas | ELife | 2017 | 1,677 |
34 | Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2 | Journal of Clinical Oncology | 2004 | 1,672 |
35 | Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1 | Journal of Clinical Oncology | 2004 | 1,669 |
36 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 | Autophagy | 2021 | 1,642 |
37 | Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab | Cell | 2017 | 1,638 |
38 | Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer | Journal of Clinical Oncology | 2018 | 1,607 |
39 | Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway | Nature | 2013 | 1,606 |
40 | Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma | Cancer Cell | 2012 | 1,600 |
41 | VEGF-targeted therapy: mechanisms of anti-tumour activity | Nature Reviews Cancer | 2008 | 1,587 |
42 | B cells and tertiary lymphoid structures promote immunotherapy response | Nature | 2020 | 1,583 |
43 | Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia | New England Journal of Medicine | 2020 | 1,577 |
44 | Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation | New England Journal of Medicine | 2018 | 1,571 |
45 | Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases | Annals of Surgery | 2004 | 1,569 |
46 | Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation | Journal of Clinical Oncology | 2009 | 1,532 |
47 | Eicosanoids and cancer | Nature Reviews Cancer | 2010 | 1,526 |
48 | Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors | New England Journal of Medicine | 2014 | 1,518 |
49 | First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial | Lancet, The | 2021 | 1,498 |
50 | Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition | Nature Cell Biology | 2004 | 1,475 |